Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013
London (PRWEB) October 24, 2013 -- Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013
Summary
GlobalData's clinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013" provides data on the Cytomegalovirus (HHV-5) Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cytomegalovirus (HHV-5) Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cytomegalovirus (HHV-5) Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
-Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
-Understand the dynamics of a particular indication in a condensed manner
-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
-Obtain discontinued trial listing for trials across the globe
-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Cytomegalovirus (HHV-5) Infections 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Cytomegalovirus (HHV-5) Infections 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
F. Hoffmann-La Roche Ltd. 33
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 33
Hoffmann-La Roche Inc. 35
Clinical Trial Overview of Hoffmann-La Roche Inc. 35
ViroPharma Incorporated 36
Clinical Trial Overview of ViroPharma Incorporated 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
AstraZeneca PLC 38
Clinical Trial Overview of AstraZeneca PLC 38
Vical Incorporated 39
Clinical Trial Overview of Vical Incorporated 39
Isis Pharmaceuticals, Inc. 40
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 40
Chimerix, Inc. 41
Clinical Trial Overview of Chimerix, Inc. 41
Gilead Sciences, Inc. 42
Clinical Trial Overview of Gilead Sciences, Inc. 42
Theraclone Sciences, Inc. 43
Clinical Trial Overview of Theraclone Sciences, Inc. 43
Genentech, Inc. 44
Clinical Trial Overview of Genentech, Inc. 44
Amgen Inc. 45
Clinical Trial Overview of Amgen Inc. 45
Cell Medica Limited 46
Clinical Trial Overview of Cell Medica Limited 46
AiCuris GmbH & Co. KG 47
Clinical Trial Overview of AiCuris GmbH & Co. KG 47
Roche Global Development 48
Clinical Trial Overview of Roche Global Development 48
AlphaVax, Inc. 49
Clinical Trial Overview of AlphaVax, Inc. 49
Sandoz Inc. 50
Clinical Trial Overview of Sandoz Inc. 50
Astellas Pharma Inc. 51
Clinical Trial Overview of Astellas Pharma Inc. 51
Novartis AG 52
Clinical Trial Overview of Novartis AG 52
Merck & Co., Inc. 53
Clinical Trial Overview of Merck & Co., Inc. 53
Clinical Trial Overview of Top Institutes / Government 54
The National Institute of Allergy and Infectious Diseases 54
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 54
National Heart, Lung, and Blood Institute 57
Clinical Trial Overview of National Heart, Lung, and Blood Institute 57
National Eye Institute 58
Clinical Trial Overview of National Eye Institute 58
Baylor College of Medicine 59
Clinical Trial Overview of Baylor College of Medicine 59
National Center for Research Resources 60
Clinical Trial Overview of National Center for Research Resources 60
Fred Hutchinson Cancer Research Center 61
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 61
Hadassah Medical Organization 62
Clinical Trial Overview of Hadassah Medical Organization 62
University of California, San Francisco 63
Clinical Trial Overview of University of California, San Francisco 63
University of Alabama at Birmingham 64
Clinical Trial Overview of University of Alabama at Birmingham 64
National Taiwan University Hospital 65
Clinical Trial Overview of National Taiwan University Hospital 65
Kobe University 66
Clinical Trial Overview of Kobe University 66
University Hospital, Limoges 67
Clinical Trial Overview of University Hospital, Limoges 67
Memorial Sloan Kettering Cancer Center 68
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 68
City of Hope National Medical Center 69
Clinical Trial Overview of City of Hope National Medical Center 69
Hospital do Rim e Hipertensao 70
Clinical Trial Overview of Hospital do Rim e Hipertensao 70
Washington University School of Medicine 71
Clinical Trial Overview of Washington University School of Medicine 71
Assistance Publique - Hopitaux de Paris 72
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 72
Duke University 73
Clinical Trial Overview of Duke University 73
Charles University 74
Clinical Trial Overview of Charles University 74
University of Pennsylvania 75
Clinical Trial Overview of University of Pennsylvania 75
Five Key Clinical Profiles 76
Appendix 108
Abbreviations 108
Definitions 108
Research Methodology 109
Secondary Research 109
About GlobalData 110
Contact Us 110
Disclaimer 110
Source 111
1.1 List of Tables
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, North America, Top Countries, 2013* 14
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 16
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, BRIC Countries, 2013* 17
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, G7 Countries, 2013* 18
Cytomegalovirus (HHV-5) Infections Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, E7 Countries, 2013* 20
Cytomegalovirus (HHV-5) Infections Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 33
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2013* 35
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroPharma Incorporated, 2013* 36
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 37
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 38
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Vical Incorporated, 2013* 39
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2013* 40
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Chimerix, Inc., 2013* 41
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2013* 42
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Theraclone Sciences, Inc., 2013* 43
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2013* 44
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2013* 45
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Medica Limited, 2013* 46
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AiCuris GmbH & Co. KG, 2013* 47
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Roche Global Development, 2013* 48
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AlphaVax, Inc., 2013* 49
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Sandoz Inc., 2013* 50
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2013* 51
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 52
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 53
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2013* 54
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 57
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2013* 58
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013* 59
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2013* 60
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2013* 61
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 62
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 63
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013* 64
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 65
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2013* 66
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Limoges, 2013* 67
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2013* 68
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2013* 69
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital do Rim e Hipertensao, 2013* 70
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2013* 71
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013* 72
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 73
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Charles University, 2013* 74
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2013* 75
List of Figures
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 16
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
Cytomegalovirus (HHV-5) Infections Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, E7 Countries (%), 2013* 20
Cytomegalovirus (HHV-5) Infections Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23
Cytomegalovirus (HHV-5) Infections Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Cytomegalovirus (HHV-5) Infections Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 109
Read the full report:
Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H2, 2013
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com
Sarah Smith, Research Advisor at Reportbuyer.com, +44 208 816 85 48, [email protected]
Share this article